TotalMarketCap

Abbott Laboratories

ABTNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$170.425 B

$98.49 -0.24%

Close of 9 Oct 2026

As of 9 Oct 2026, Abbott Laboratories (ABT) has a market capitalization of $170.4B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$44.3B

#94 by revenue

Earnings

$6.52B

#80 by earnings

Shares outstanding

1,730,383,296

Latest filing cover page

P/E ratio

26.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #5NovartisNVS$273.1B
  2. #6AstrazenecaAZN$246.2B
  3. #7Abbott LaboratoriesABT$170.4B
  4. #8Novo Nordisk A SNVO$169.1B
  5. #9PfizerPFE$158.6B

What if Abbott Laboratories were worth as much as…

Open the what-if tool →

Gold $29.1T

$16,795.04

Per share 171× higher

Bitcoin $1.66T

$959.66

Per share 9.74× higher

Nvidia $5.55T

$3,210.02

Per share 32.6× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Abbott Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.